好色先生

好色先生

Explore the latest content from across our publications
Join The AAN

Log In

Forgot Password?
Create New Account

Loading... please wait

2013 Annual Meeting | Epilepsy Co-morbidities

Friday 03/22/13
01:00 PM - 05:00 PM Add To Calendar
This program will be presented both in-person and online
This program is not expected to be available in the meeting's On Demand product.
Half-Day Course
William H. Theodore, MD, FAAN
Participants should have improved knowledge of the etiology, pathophysiology, and clinical impact for the comorbidities to be discussed. Participants should be able to provide their patients with better information as well as prevention and treatment strategies.
No CME available
Patient Care & Procedural Skills, Interpersonal and Communication Skills, Medical Knowledge
Subspecialty in Focus
Other, Trainee, General Neurologist, Specialist Neurologist, Non-neurologist
Didactic, Interactive, Audience Participation
Event Timeline
01:00 PM - 01:40 PM SUDEP: The Imperative for Research and Counseling
Elson L. So, MD, FAAN
01:40 PM - 01:50 PM Questions and Answers
01:50 PM - 02:30 PM Mechanisms of Cognitive Comorbidities
Frances E. Jensen, MD, FAAN
02:30 PM - 02:40 PM Questions and Answers
02:40 PM - 03:00 PM Break
03:00 PM - 03:40 PM Depression and Epilepsy
William H. Theodore, MD, FAAN
03:40 PM - 03:50 PM Questions and Answers
03:50 PM - 04:30 PM Comorbidities in Women with Epilepsy
Cynthia L. Harden, MD
04:30 PM - 05:00 PM Questions and Answers
Faculty Disclosures
William H. Theodore, MD, FAAN Dr. Theodore has a non-compensated relationship as a Treasurer and vice president with American Epilepsy Society that is relevant to AAN interests or activities.
Elson L. So, MD, FAAN Dr. So has nothing to disclose.
Frances E. Jensen, MD, FAAN Dr. Jensen has received research support from Passages Bio.
Cynthia L. Harden, MD Dr. Harden has received personal compensation for serving as an employee of Xenon Pharmaceuticals Inc.. Dr. Harden has stock in Xenon Pharmaceuticals Inc.. Dr. Harden has received intellectual property interests from a discovery or technology relating to health care.